Scholtz & Company, LLC
- SEC CIK
- 0001606134
- Latest filing
- Aug 11, 2026
EW holding history
Edwards Lifesciences Corp in every 13F filed by Scholtz & Company, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
EW overviewAll 13F holders of EWFull Q2 2026 holdings
- Shares (Q1 2023)
- 0
- Sold out in Q1 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2023 | 0 | $0 | 0.0% | −18,001−100.0% | Sold out | Holders |
| Q4 2022 | 18,001 | $1.34M | 1.0% | −60−0.3% | Reduced | Holders |
| Q3 2022 | 18,061 | $1.35M | 1.0% | −18,074−50.0% | Reduced | Holders |
| Q2 2022 | 36,135 | $3.44M | 2.1% | −973−2.6% | Reduced | Holders |
| Q1 2022 | 37,108 | $4.37M | 1.7% | −3,108−7.7% | Reduced | Holders |
| Q4 2021 | 40,216 | $5.21M | 1.7% | −5,274−11.6% | Reduced | Holders |
| Q3 2021 | 45,490 | $5.15M | 1.8% | −1,857−3.9% | Reduced | Holders |
| Q2 2021 | 47,347 | $4.90M | 1.7% | +4,150+9.6% | Added | Holders |
| Q1 2021 | 43,197 | $3.61M | 1.4% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.